SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : RSHN - RushNet, Inc.
RSHN 0.0003000.0%Nov 20 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ThinkingBig who wrote (550)10/28/2005 10:46:14 PM
From: donpat  Read Replies (2) of 3116
 
Re --Ginseng Viral Care--

There was that CMAJ article on the double blind ginseng trials which proved its efficacy against the common cold and flu:
cmaj.ca


CV Technologies was the company involved in the CMAJ article.

They have a product containing ginseng extract that is sold widely to ward off the common cold and flu. It is called COLD-fX. This is their web site:
cvtechnologies.com

This is the stock symbol - CVQ.V:
finance.yahoo.com

Note the continual rise from Jan/03 at pennies to $4 today. Thanks to ginseng! I don't see why RSHN should do anything less!

This is the relevant US patent involved:
United States Patent 6,432,454
Shan , et al. August 13, 2002

Processes of making north american ginseng fractions, products containing them, and use as immunomodulators

Abstract
The invention is directed to chemical processes of preparing fractions from North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.

Inventors: Shan; Jacqueline J. (Edmonton, CA); Pang; Peter K. T. (Edmonton, CA); Huang; Buhan (Edmonton, CA); Ling; Lei (Edmonton, CA)
Assignee: C. V. Technologies, Inc. (Edmonton, CA)
Appl. No.: 581161
Filed: July 27, 2000
PCT Filed: November 11, 1998
PCT NO: PCT/US90/25724

patft.uspto.gov

Bottom line?
RSHN will zing with ginseng!
Get ready to rumble.

PS:
I also follow and own shares in another immunostimulant company named Artec - ATKJ - which has an immunostimulant product called Tubercin very likely a terrific cancer fighting drug. I contemplated a link between RSHN and ATKJ to link Rush ginseng and Tubercin here:
Message 21836111
Will it fly?
I hope so. BWDIK.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext